Literature DB >> 9733402

The Yelandur study: a community-based approach to epilepsy in rural South India--epidemiological aspects.

K S Mani1, G Rangan, H V Srinivas, S Kalyanasundaram, S Narendran, A K Reddy.   

Abstract

Data on the epidemiology of epilepsy in a rural community in a developing country would be of value in planning a decentralized management of this malady in its early stages commensurate with available local resources. A detailed screening instrument covering various seizure types was used by trained paramedical workers in a door-to-door survey of a population of 64,963 in rural South India. The prevalence period was from 1 April 1990 to 31 March 1991. The crude prevalence rate per 1000 for active epilepsy was 4.38 for males, 3.40 for females and 3.91 for both. The minimum and maximum prevalence rates, the latter computed from a validation sample, were 3.91 and 4.63 for active epilepsy; 0.28 and 0.77 for inactive epilepsy and 4.19 and 5.41 for life-time prevalence. In addition, corresponding figures for hot-water epilepsy, a type of reflex epilepsy peculiar to this area, were 2.49 and 2.99 for active phase; 0.35 and 0.85 for inactive phase and 2.85 and 3.83 for life-time prevalence. The incidence rate for epilepsy was 49.3 per 100,000, the same as in developed countries. These data do not support the concept that the prevalence of epilepsy in developing countries is twice that in the developed world. However, the role of local/regional variations should be borne in mind before extrapolating the figures to an entire country.

Entities:  

Mesh:

Year:  1998        PMID: 9733402     DOI: 10.1016/s1059-1311(98)80019-8

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  23 in total

Review 1.  The descriptive epidemiology of epilepsy-a review.

Authors:  Poonam Nina Banerjee; David Filippi; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

2.  Clinical, Demographic, and Electroencephalographic Profile of Hot-Water Epilepsy in Children.

Authors:  Narmadham K Bharathi; Sanjay K Shivappa; Vykuntaraju K Gowda; Suman Shivalingaiah; Asha Benakappa
Journal:  Indian J Pediatr       Date:  2021-01-08       Impact factor: 1.967

3.  Familial autosomal dominant reflex epilepsy triggered by hot water maps to 4q24-q28.

Authors:  Rinki Ratnapriya; Parthasarthy Satishchandra; S Dilip; Girish Gadre; Anuranjan Anand
Journal:  Hum Genet       Date:  2009-07-14       Impact factor: 4.132

4.  Epilepsy: The future scenario.

Authors:  H V Srinivas
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

Review 5.  Recent advances in febrile seizures.

Authors:  Rekha Mittal
Journal:  Indian J Pediatr       Date:  2014-08-08       Impact factor: 1.967

6.  The reasons for the epilepsy treatment gap in Kilifi, Kenya: using formative research to identify interventions to improve adherence to antiepileptic drugs.

Authors:  Julie A Carter; Catherine S Molyneux; Caroline K Mbuba; Jo Jenkins; Charles R J C Newton; Sally D Hartley
Journal:  Epilepsy Behav       Date:  2012-11-15       Impact factor: 2.937

7.  Pediatric epilepsy: The Indian experience.

Authors:  Pradnya Gadgil; Vrajesh Udani
Journal:  J Pediatr Neurosci       Date:  2011-10

8.  Prevalence and Incidence of Epilepsy in an Elderly and Low-Income Population in the United States.

Authors:  Derek H Tang; Daniel C Malone; Terri L Warholak; Jenny Chong; Edward P Armstrong; Marion K Slack; Chiu Hsieh Hsu; David M Labiner
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

9.  Reflex neurosis (NEAD).

Authors:  V A P Ghorpade
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

10.  Need for a national epilepsy control program.

Authors:  M Tripathi; D C Jain; M Gourie Devi; S Jain; V Saxena; P S Chandra; K Radhakrishnan; M Behari; M Gupta; V Puri; M M Mehndiratta; K Bala; K S Anand; S Rawat; P U Shah; S Gulati; S Johri; V V Nadkarni; P Sarat Chandra; D Bachani
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.